Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL V GENUARDI

Allopathic & Osteopathic Physicians Internal Medicine Advanced Heart Failure and Transplant Cardiology

NPI
1275897746
CMS profile
770722
Location
PHILADELPHIA, PA

General Payments · PY2018–2024

$7,792.65

  • Reported across 59 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,704.29

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $1,367.54 7
Food and Beverage $336.75 7

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Abbott Laboratories $1,534.66 10
CVRx Inc. $152.08 3
NOVARTIS PHARMACEUTICALS CORPORATION $17.55 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,027.50 2
PY2019 $2,172.24 19
PY2020 $377.07 6
PY2021 $1,285.29 7
PY2022 $841.18 5
PY2023 $385.08 6
PY2024 $1,704.29 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $20.90 06/24/2024 Food and Beverage Undisputed 01/23/2026 1124950161 CMS
Abbott Laboratories $92.75 07/17/2024 Food and Beverage Undisputed 01/23/2026 1124950165 CMS
Abbott Laboratories $750.88 10/10/2024 Travel and Lodging Undisputed 01/23/2026 1125399902 CMS
Abbott Laboratories $9.02 10/10/2024 Travel and Lodging Undisputed 01/23/2026 1125399914 CMS
Abbott Laboratories $53.47 11/05/2024 Food and Beverage Undisputed 01/23/2026 1124950169 CMS
Abbott Laboratories $117.48 11/05/2024 Travel and Lodging Undisputed 01/23/2026 1125399904 CMS
Abbott Laboratories $117.36 11/05/2024 Travel and Lodging Undisputed 01/23/2026 1125399906 CMS
Abbott Laboratories $174.70 11/05/2024 Travel and Lodging Undisputed 01/23/2026 1125399908 CMS
Abbott Laboratories $116.47 11/05/2024 Travel and Lodging Undisputed 01/23/2026 1125399910 CMS
Abbott Laboratories $81.63 11/05/2024 Travel and Lodging Undisputed 01/23/2026 1125399912 CMS
CVRx, Inc. $85.67 02/14/2024 Food and Beverage Undisputed 01/23/2026 1128562126 CMS
CVRx, Inc. $50.92 02/21/2024 Food and Beverage Undisputed 01/23/2026 1128562128 CMS
CVRx, Inc. $15.49 04/10/2024 Food and Beverage Undisputed 01/23/2026 1128562130 CMS
Novartis Pharmaceuticals Corporation $17.55 04/29/2024 Food and Beverage Undisputed 01/23/2026 1086951087 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.